Yoke YK-YW5 Ethylene Oxide Residual Content Analyzer for Medical Devices

Overview

The Yoke YK-YW5 Ethylene Oxide Residual Content Analyzer is a dedicated benchtop photometric system engineered for the quantitative determination of residual ethylene oxide (EO) in medical devices—particularly post-sterilization masks, gowns, catheters, and other single-use healthcare products. It operates on a validated colorimetric principle aligned with ISO 10993-7:2008 and USP , wherein EO residues are hydrolyzed to ethylene glycol under controlled acidic conditions, oxidized to formaldehyde by periodic acid (H₅IO₆), and subsequently reacted with Schiff’s reagent (pararosaniline–sodium bisulfite) to yield a stable magenta chromophore. Absorbance is measured at 560 nm using a precision optical path optimized for low-concentration detection in aqueous extracts. The instrument integrates factory-calibrated working curves traceable to NIST-traceable EO reference standards, eliminating user-dependent calibration drift and ensuring inter-laboratory reproducibility.

Key Features

• Pre-installed, NIST-traceable calibration curves for EO quantification—no manual standard curve generation required
• Complete reagent kit included (100 assays): pre-weighed, stability-verified reagents including 0.1 mol/L HCl, 5 g/L periodic acid, 10 g/L sodium thiosulfate, 100 g/L sodium sulfite, and freshly prepared pararosaniline–bisulfite reagent
• Dedicated thermal incubation module maintaining 35–37 °C ± 0.5 °C for consistent chromophore development kinetics
• High-stability LED-based photometer with 560 nm interference filter (FWHM ≤ 10 nm) and dual-beam referencing for drift compensation
• Integrated sample handling protocol compliant with ISO 10993-7 Annex B (extraction via limit extraction method using 0.1 mol/L HCl)
• Robust architecture designed for GLP-compliant environments: audit trail enabled, user-accessible calibration logs, and password-protected method storage

Sample Compatibility & Compliance

The YK-YW5 supports solid and semi-rigid polymeric medical device samples—including nonwovens, PVC tubing, silicone elastomers, and polypropylene filters—as specified in ISO 10993-7 Section 5.2. Sample preparation follows the “limit extraction” procedure: representative high-residue components are cut into ≤5 mm fragments or 10 mm² sections, extracted with 10 mL of 0.1 mol/L hydrochloric acid for 60 min at ambient temperature, and filtered prior to analysis. The system meets essential requirements of ISO/IEC 17025:2017 for testing laboratories and supports full compliance documentation for FDA 21 CFR Part 820 (QSR) and EU MDR Annex II technical documentation. All reagents conform to ACS-grade specifications per ASTM E2913-22; assay sensitivity achieves a practical detection limit of 0.5 µg/g (ppb w/w) with intra-assay CV < 3.2% (n = 12).

Software & Data Management

The embedded firmware provides intuitive touchscreen navigation with English-language UI, configurable report templates (PDF/CSV export), and automatic calculation of EO content (µg/g) using the standardized formula: CEO = 1.775 × V × C₁ × 1000. Data integrity safeguards include electronic signatures, time-stamped audit trails, and immutable storage of raw absorbance values, calibration history, and operator metadata. Exported reports contain full traceability: instrument ID, reagent lot numbers, extraction parameters, and reference to ISO 10993-7:2008 Clause 7.2. Optional USB data transfer enables integration with LIMS platforms supporting ASTM E1384-compliant structured data exchange.

Applications

• Residual EO quantification in sterilized surgical masks, respirators (e.g., N95), and face shields per ISO 10993-7 and GB/T 14233.1–2022
• Batch release testing for EO-sterilized Class I–III medical devices under MDR 2017/745 Annex I General Safety and Performance Requirements
• Process validation support during EO sterilization cycle development and PQ studies
• Stability-indicating analysis of EO residue migration over shelf life (accelerated and real-time conditions)
• QC/QA testing in contract manufacturing organizations (CMOs) serving global medical device OEMs

FAQ

Does the YK-YW5 require daily recalibration?
No. Factory-installed calibration curves remain valid for ≥100 assays when stored under recommended conditions (2–8 °C for reagents; instrument operated at 15–30 °C). A verification check using the supplied EO reference control solution is recommended before each analytical session.
Can the instrument be used for non-medical EO testing (e.g., food packaging)?
While the chemistry is applicable, the YK-YW5 is configured and validated exclusively for ISO 10993-7–compliant medical device testing. Adaptation for other matrices requires full method validation per ICH Q2(R2) guidelines and is not supported out-of-the-box.
Is the system compliant with FDA 21 CFR Part 11?
The firmware supports electronic records and signatures but requires local configuration of role-based access controls and network-level audit logging to achieve full Part 11 compliance. A validation package (IQ/OQ/PQ protocols) is available upon request.
What is the shelf life of the included reagent kit?
Unopened reagents retain stability for 12 months when refrigerated at 2–8 °C. After first opening, periodic acid and Schiff’s reagent must be used within 7 days; HCl and thiosulfate solutions remain stable for 30 days.
How is measurement uncertainty estimated for reported EO values?
Uncertainty is propagated from three primary contributors: sample mass (±0.001 g), extract volume (±0.02 mL), and photometric absorbance (±0.003 AU), yielding an expanded uncertainty (k=2) of ±7.3% for results between 1–10 µg/g, as verified per ISO/IEC Guide 98-3.